Ian Bradley from PA Consulting Group, the leading international management, systems and technology consultancy, will provide insight on how to successfully negotiate financial terms in pharmaceutical licensing deals, in a paper to be given at Vision in Business's Structuring and Negotiating Licensing Deals Conference in Brussels on 17 July 2002.
The paper will outline the benefits of drawing together elements of business development activity, traditionally seen as separate 'silos' within businesses - in-licensing processes, financial analytics and deal negotiation. This insight will be of particular value to business development managers and therapy area managers in pharmaceutical companies and their technology partners, who together face the challenge of filling product pipelines with quality candidates to meet the expectations of shareholders.
Ian will explain how businesses can use collaborative processes, strategic decision frameworks and insight-based analytical tools, to improve decision quality, raise 'better-deal' success rates and - ultimately - increase shareholder value as a result of improved product pipelines.
Ian is a member of PA's Life Sciences team where he specialises in developing and implementing analytical tools and processes for business development decision support. In presenting these insights, Ian will be drawing on his experiences in leading similar assignments for PA's clients in the pharmaceutical, biotechnology and medical device industries.
PA Consulting Group's life sciences expertise focuses on strategic alliance management and partnering; R&D performance improvement; manufacturing and operational excellence; technology assessment with commercial strategy for pharmaceutical, medical device and biotechnology companies, and for related businesses across their life sciences value chains.
Structuring and Negotiating Licensing Deals, Hotel le Plaza, Brussels, Belgium, 16-17 July 2002
- Ends -